The use of antibodies against the IL-2 receptor in transplantation

被引:109
作者
Waldmann, TA
O'Shea, J
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] NIAMSD, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S0952-7915(98)80215-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Humanized monoclonal antibodies that recognize the a chain of the IL-2 receptor (e.g. daclizumab) have been used to prevent allograft rejection, since this chain is expressed by T cells participating in allograft rejection but not by resting T cells. In a randomized trial, when added to standard cyclosporin-based immunosuppression, daclizumab significantly reduced the frequency of acute rejection of renal transplants.
引用
收藏
页码:507 / 512
页数:6
相关论文
共 66 条
[61]   RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC [J].
WALDMANN, TA ;
WHITE, JD ;
CARRASQUILLO, JA ;
REYNOLDS, JC ;
PAIK, CH ;
GANSOW, OA ;
BRECHBIEL, MW ;
JAFFE, ES ;
FLEISHER, TA ;
GOLDMAN, CK ;
TOP, LE ;
BAMFORD, R ;
ZAKNOEN, S ;
ROESSLER, E ;
KASTENSPORTES, C ;
ENGLAND, R ;
LITOU, H ;
JOHNSON, JA ;
JACKSONWHITE, T ;
MANNS, A ;
HANCHARD, B ;
JUNGHANS, RP ;
NELSON, DL .
BLOOD, 1995, 86 (11) :4063-4075
[62]  
WALDMANN TA, 1991, J BIOL CHEM, V266, P2681
[63]   THE IL-2/IL-2 RECEPTOR SYSTEM - A TARGET FOR RATIONAL IMMUNE INTERVENTION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 159-164, 1993) [J].
WALDMANN, TA .
IMMUNOLOGY TODAY, 1993, 14 (06) :264-270
[64]  
WALDMANN TA, 1988, BLOOD, V72, P1805
[65]   INVOLVEMENT OF THE JAK-3 JANUS KINASE IN SIGNALING BY INTERLEUKIN-2 AND INTERLEUKIN-4 IN LYMPHOID AND MYELOID CELLS [J].
WITTHUHN, BA ;
SILVENNOINEN, O ;
MIURA, O ;
LAI, KS ;
CWIK, C ;
LIU, ET ;
IHLE, JN .
NATURE, 1994, 370 (6485) :153-157
[66]   SPECIFIC TOLERANCE TO NEURAL ALLOGRAFTS INDUCED WITH AN ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR [J].
WOOD, MJA ;
SLOAN, DJ ;
DALLMAN, MJ ;
CHARLTON, HM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :597-603